The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study.

Front Med (Lausanne) · 2022 · PMC9393583 · PMID 36004370

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Patients on VDZ showed a higher rate of clinical worsening since the introduction of the biologic agent compared with non-gut selective therapies, even if the results did not reach statistical significance (15.5 vs. 7.3%, 7/45 vs. 13/179, p = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.